MedTrace Logo

COrticosteroids in acUte uRticAria in emerGency dEpartment

NCT03545464 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2025-09-22

No results posted yet for this study

Summary

To demonstrate the non-inferiority of the efficacy of a single antihistamine in comparison with an association of antihistamine and corticosteroid in the treatment of acute urticaria in emergency departments

Conditions

  • Urticaria
  • Angiœdema

Interventions

DRUG

Placebo Oral Tablet

Placebo of cortancyl Oral Tablet 20mg

DRUG

Cortancyl Oral Tablet

Cortancyl oral Tablet 20 mg

DRUG

Levocetirizine Oral Tablet

Levocetirizine Oral Tablet 5 mg

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Nicolas JAVAUD, M.D,Ph.D · France Hospital Louis MOURIER Colombes, Ile De France, France, 92700

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-21
Primary Completion
2025-02-28
Completion
2025-09-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03545464 on ClinicalTrials.gov